Amphastar Pharmaceuticals News and Activities
Presence
Amphastar Pharmaceuticals develops, makes, and sells generic and specialty medicines. Its products include injectable drugs, inhalation therapies, and diagnostic ingredients for hospitals, clinics, and other healthcare providers.
Amphastar Pharmaceuticals products and services overview:
- Injectable medicines
- Inhalation therapies
- Generic drugs
- Specialty pharmaceuticals
- Diagnostic ingredients
- Nasal products
Revenue: ~$730 million
Employees: 1,800
Headquarters: Rancho Cucamonga, United States (USA)
Amphastar Pharmaceuticals is one of the...
Amphastar Pharmaceuticals is a company listed under the stock ticker AMPH (US).
Executives
View the org chart displaying its 11 main executives
Most searched biographies at Amphastar Pharmaceuticals
- Jack Zhang, Chief Executive Officer, President, Chief Scientific O...
- Richard Prins, Lead Independent Director
- Gayle Deflin, Director
Create your alert
to follow the executive moves at Amphastar Pharmaceuticals.
Pharmaceuticals
Amphastar Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Amphastar Pharmaceuticals
- Media/News | AMPHASTAR
- RSS News Feeds | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020 | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020 | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference | Amphastar Pharmaceuticals, Inc.
- Press Releases | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial | Amphastar Pharmaceuticals, Inc.
- View more press releases Close
Social media about Amphastar Pharmaceuticals
- Amphastar Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Amphastar Pharmaceuticals on LinkedIn, X (Twitter) & YouTube
